Today we’re going to cover the second article in a two part series that takes a look at the ongoing studies and clinical trials specific to management of migraine in adults, including acute migraine treatment and migraine prevention (both chronic migraine prevention and episodic migraine prevention). The focus of Part 1 was Acute Migraine Treatment […]
The Endocrine Society’s annual meeting, ENDO 2024, was held from June 1-4 in Boston, MA. This event served as a leading gathering for professionals in the field of endocrinology. The conference showcased esteemed experts and influential thought leaders who provided insightful presentations on cutting-edge research, treatments, and developments in endocrine disorders. Highlighted below are some […]
The Annual Meeting of the American Society of Clinical Oncology (ASCO) was held from May 31 to June 4, 2024, in Chicago, IL. This event serves as a pivotal gathering for healthcare professionals committed to enhancing patient care and outcomes within the field of oncology. A prominent topic of discussion at ASCO24 was lung cancer. […]
In this post, we will be taking a closer look at some of the most popular neurology-related articles recently published across medical journals. Burden of Stroke Attributable to Nonoptimal Temperature in 204 Countries and Territories Effect of Intermittent Oro-Esophageal Tube Feeding in Bulbar Palsy After Ischemic Stroke: A Randomized Controlled Study Downstream Biomarker Effects of […]
The 2024 Vascular Annual Meeting (VAM24) will be held from June 19-22 in Chicago, Illinois. It is the Society of Vascular Surgery’s (SVS) premier meeting, offering a wealth of valuable scientific content tailored for every member of the vascular care team. If you have not already done so, we recommend registering here for this year’s […]
Breyanzi (Bristol Myers Squibb)Expanded Indication Retevmo (Eli Lilly) Expanded Indication Onyda XR (Tris Pharma) Bkemv (Amgen)Biosimilar to Soliris Opuviz (Biogen) Biosimilar to Eylea Yesafili (Biocon Biologics) Biosimilar to Eylea Imdelltra (Amgen) Clinolipid (Baxter) Expanded Indication ColoSense (Geneoscopy) New Formulation Myhibbin (Azurity Pharmaceuticals) New Formulation Cyltezo (Boehringer Ingelheim) New Formulation Sign up for alerts and stay informed on […]
Sign up for alerts and stay informed on the latest published guidelines, FDA decisions, and more! Copyright © 2024 Guideline Central, All rights reserved.
The Food and Drug Administration (FDA) protects public health by guaranteeing the safety, effectiveness, and security of pharmaceuticals and medical devices. The Prescription Drug User Fee Act (PDUFA) date marks the deadline by which the FDA must complete its review of drug applications. Occasionally, an advisory committee (AdCom) meeting is convened to assess the drug […]
Amyotrophic lateral sclerosis (ALS), commonly referred to as Lou Gehrig’s disease, is a neurological disorder that impacts the motor neurons responsible for controlling voluntary muscle movement and breathing, according to the National Institutes of Health (NIH). The Centers for Disease Control and Prevention (CDC) has reported that at least 16,000 Americans are affected by ALS. […]
In our first installment of our Guidelines International Series, we will be examining the British Society for Haematology (BSH). As the largest haematology organization in the United Kingdom (UK), boasting over 3,000 members worldwide, BSH is the premier membership organization for haematology professionals in the UK. BSH is dedicated to promoting excellence in the study, […]
Our Guidelines Rundown Series continues with a new article focusing on multiple sclerosis (MS). Currently, there are limited guidelines available on MS, all of which are provided by the American Academy of Neurology. These guidelines encompass a range of topics including vaccines and immunizations, therapies, alternative medicine, as well as the assessment and management of […]
In this post, we will be taking a closer look at some of the most popular urology-related articles recently published across medical journals. Current and Emerging Strategies to Curb Antibiotic-Resistant Urinary Tract Infections A Multicenter Prospective Randomized Controlled Trial Comparing Cxbladder Triage to Cystoscopy in Patients With Microhematuria. The Safe Testing of Risk for Asymptomatic […]
According to the National Institutes of Health (NIH), around 13% of women will receive a cancer diagnosis at some stage in their lives. In 2021, an estimated 3,972,256 women were living with cancer in the United States. The most prevalent cancer subtype is HR+/HER2-, with an age-adjusted rate of 90 new cases per 100,000 women, […]
The American College of Physicians (ACP) released a new clinical guideline on April 19, 2024, for Newer Pharmacologic Treatments in Adults With Type 2 Diabetes. This guideline focused specifically on three classes of medications commonly used for patients with Type 2 Diabetes Mellitus: While the guideline is relatively short, consisting of only three key recommendations, […]
For this installment of our Guidelines Side-By-Side Series, we’re going to take a look at the current guidelines for atopic dermatitis (AD), commonly referred to as eczema. It is a chronic inflammatory skin condition, identified by dry, itchy skin that may release clear fluid when scratched. The National Institutes of Health (NIH) estimates that this […]
Our Guidelines Rundown Series progresses with a new article focused on tuberculosis. Numerous guidelines on tuberculosis are currently available, published by nearly a dozen different medical societies and organizations. The most recent guideline, issued by the World Health Organization, stands out as it leads the global initiative to eradicate tuberculosis by advocating for universal access […]
The American Gastroenterological Association’s (AGA) annual meeting was held in Washington, DC from May 18-21, 2024. Digestive Disease Week® (DDW2024) is considered the leading event for gastroenterology professionals, featuring innovative advancements, networking opportunities, and the most recent research in the field. Today, we will explore some of the fascinating research presented at the DDW2024, with […]
May is High Blood Pressure Education Month. High blood pressure, also known as hypertension, is a significant controllable risk factor for stroke and heart disease. In this article, we’re going to review the 2022 Blood Pressure Targets in Adults with Hypertension guideline from the American Academy of Family Physicians (AAFP) published on November 14, 2022. […]
The Heart Rhythm Society’s 2024 Annual Meeting (HRS2024) was held in Boston from May 16-19, 2024. This prestigious event showcased cutting-edge research and advancements in the fields of cardiology and electrophysiology (EP). Today, we will explore some of the fascinating research presented at the HRS2024 Annual Meeting, with a specific focus on pulsed field ablation. […]
Welcome to our succinct summaries of the most recent healthcare news and research. Keep yourself informed with our easily digestible updates sourced from medical media and news outlets. Associations of Testosterone and Related Hormones With All-Cause and Cardiovascular Mortality and Incident Cardiovascular Disease in Men: Individual Participant Data Meta-analyses Study Details | Source Consumption of Olive […]
Today we’re going to cover the first article in a two-part series that takes a look at the ongoing studies and clinical trials specific to management of migraine in adults, including acute migraine treatment and migraine prevention (both chronic migraine prevention and episodic migraine prevention). For Part 1 we’ll be starting with Acute Migraine Treatment […]
Today we’re going to look at the ongoing studies and clinical trials specific to management of schizophrenia in adults, including in acutely psychotic people with schizophrenia and relapse prevention. The below list was curated by assessing the ongoing Phase 3 trials for migraine treatments, specific for adults, and based in the United States. The dates […]
During Women’s Health Awareness Month, it is crucial to address menopause-related issues with informed strategies. The prevalence of vasomotor symptoms of menopause ranges from 50% to 82% among US women experiencing natural menopause. Additionally, genitourinary syndrome of menopause affects 27% to 84% of postmenopausal women. Breast cancer impacts approximately one in eight women in the […]
Now that you’ve identified the barriers and prioritized specific interventions as discussed in our previous article on Step 4: Determining Interventions To Mitigate The Identified Barriers, it’s time to begin looking at actual implementation. This includes following through with the previous plans you’ve put in place, and the distribution of various resources to support your […]
This is our first post in a new series called “Guidelines+ Monographs”. In this series we provide an overview of a single medication or therapeutic agent, and then compare how it is positioned across all current guidelines that the medication is indicated for. This may be a single indication/guideline in some cases, or multiple indications […]